Convergent pathways in Parkinson’s disease

被引:0
|
作者
Marta Cherubini
Richard Wade-Martins
机构
[1] University of Oxford,Oxford Parkinson’s Disease Centre, Department of Physiology, Anatomy and Genetics, Le Gros Clark Building
来源
Cell and Tissue Research | 2018年 / 373卷
关键词
Parkinson’s disease; Dopamine neurons; Autophagy; Calcium; Intracellular trafficking;
D O I
暂无
中图分类号
学科分类号
摘要
Preferential degeneration of dopamine neurons (DAn) in the midbrain represents the principal hallmark of Parkinson’s disease (PD). It has been hypothesized that major contributors to DAn vulnerability lie in their unique cellular physiology and architecture, which make them particularly susceptible to stress factors. Here, we report a concise overview of some of the cell mechanisms that may exacerbate DAn sensitivity and loss in PD. In particular, we highlight how defective protein sorting and clearance, endoplasmic reticulum stress, calcium dyshomeostasis and intracellular trafficking converge to contribute synergistically to neuronal dysfunction in PD pathogenesis.
引用
收藏
页码:79 / 90
页数:11
相关论文
共 50 条
  • [41] Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease
    Burbulla, Lena F.
    Krueger, Rejko
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 306 (1-2) : 1 - 8
  • [42] Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease
    Chu, Charleen T.
    NEUROSCIENCE LETTERS, 2019, 697 : 66 - 71
  • [43] Reward pathways in Parkinson's disease: Clinical and theoretical implications
    Torta, Diana M. E.
    Castelli, Lorys
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2008, 62 (02) : 203 - 213
  • [44] Insights into mitochondrial quality control pathways and Parkinson's disease
    Lehmann, Susann
    Martins, L. Miguel
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (06): : 665 - 671
  • [45] Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study
    Durrenberger, Pascal. F.
    Gruenblatt, Edna
    Fernando, Francesca S.
    Monoranu, Camelia Maria
    Evans, Jordan
    Riederer, Peter
    Reynolds, Richard
    Dexter, David T.
    PARKINSONS DISEASE, 2012, 2012
  • [46] Editorial: Protein Degradation Pathways in Parkinson's Disease and Neurodegeneration
    Volta, Mattia
    Lewis, Patrick A.
    Lobbestael, Evy
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [47] Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map
    Kazuhiro A. Fujita
    Marek Ostaszewski
    Yukiko Matsuoka
    Samik Ghosh
    Enrico Glaab
    Christophe Trefois
    Isaac Crespo
    Thanneer M. Perumal
    Wiktor Jurkowski
    Paul M. A. Antony
    Nico Diederich
    Manuel Buttini
    Akihiko Kodama
    Venkata P. Satagopam
    Serge Eifes
    Antonio del Sol
    Reinhard Schneider
    Hiroaki Kitano
    Rudi Balling
    Molecular Neurobiology, 2014, 49 : 88 - 102
  • [48] Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease
    Cenci, M. Angela
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 600 - 604
  • [49] Pathways mediating abnormal intracortical inhibition in Parkinson's disease
    MacKinnon, CD
    Gilley, EA
    Weis-McNulty, A
    Simuni, T
    ANNALS OF NEUROLOGY, 2005, 58 (04) : 516 - 524
  • [50] Interhemispheric pathways in agenesis of the corpus callosum and Parkinson's disease
    Lizarraga, Karlo J.
    Saravanamuttu, James
    Baarbe, Julianne K.
    Lang, Anthony E.
    Chen, Robert
    BRAIN STIMULATION, 2020, 13 (02) : 360 - 362